Explore company profiles, quarterly results, announcements and ownership disclosures.
Loading the company view…
Bal Pharma Limited (NSE: BALPHARMA), ISIN INE083D01012 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
BALPHARMA last traded at ₹83.45 (+1.13%), with a 52-week range of ₹60.00 to ₹124.60 (as of 6 Nov 2026).
Shareholding as of Sep 2026: promoters 50.86%, FIIs 0.28%, DIIs 0.00%, mutual funds 0.00%.
EquiSense Score (ECS): 61/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.